Athens Research & Technology

Athens Research & Technology

Athens Research and Technology, Inc. (ART) is a dynamic life science company and recipient of the Globe Award as Georgia’s 2022 Exporter of the Year. Since 1986, ART has been a key player in the advancement of essential medical diagnostics and therapies.

Renowned for industry-standard native protein purification, ART specializes in producing natural human and animal proteins critical to academic research and manufacturing in the Clinical Diagnostic, Cell Culture Media, and Standards/Calibration industries.

For over 36 years, ART products have been sought after by prominent academic researchers and biotech companies for high-impact research published in Nature, Science, & Cell journals. Their proteins have been crucial for Alzheimer’s, Cancer, Cardiac, Pulmonary, and Covid-19 research.

Envisioned by local physicians and a University of Georgia researcher, ART was one of the first Life Science start-ups to launch from the University of Georgia incubator, serving as a model for success to many subsequent companies.

Committed to People, Purpose, & Proteins, ART places emphasis on attracting talent, developing the next generation of industry-leading Protein Chemists and keeping quality proteins at the forefront of research for the world’s most complex medical challenges. Their commitment overflows into the Athens, GA, community, ensuring the health and strength of their neighbors and the growth of the local economy.

After 36 years, ART holds a breadth of knowledge of proteins and purification processes, allowing them to purify even the most complex and least abundant proteins in the human body.